AE Wealth Management Boosts Stake in Boston Scientific

Institutional investor increases holdings in medical device company

Apr. 18, 2026 at 7:06am

Got story updates? Submit your updates here. ›

An extreme close-up of intricately engineered medical device components, conveying the complex, high-precision engineering behind Boston Scientific's products.A close-up view of the advanced medical technology that powers Boston Scientific's innovative devices.Marlborough Today

AE Wealth Management LLC, a financial advisory firm, has significantly increased its stake in Boston Scientific Corporation, a leading medical device manufacturer. The firm raised its position in Boston Scientific shares by over 1,100% in the fourth quarter, according to a recent SEC filing.

Why it matters

This move by AE Wealth Management suggests increased institutional confidence in Boston Scientific's long-term growth prospects. As a major player in the medical technology industry, Boston Scientific's performance is closely watched by investors and analysts.

The details

According to the 13F filing, AE Wealth Management now owns 177,883 shares of Boston Scientific, up from just 14,268 shares in the previous quarter. This represents a 1,146.7% increase in the firm's holdings of the medical equipment provider's stock. The shares were valued at $16.96 million at the end of the reporting period.

  • AE Wealth Management increased its Boston Scientific stake in the fourth quarter of 2025.
  • The 13F filing detailing the increased holdings was submitted in April 2026.

The players

AE Wealth Management LLC

A financial advisory firm that manages investments and provides wealth management services.

Boston Scientific Corporation

A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching Boston Scientific's upcoming earnings reports and any further changes in institutional ownership of the stock.

The takeaway

The significant increase in AE Wealth Management's Boston Scientific holdings indicates that major investors see strong potential in the medical device company's future performance, despite recent market volatility.